Theriva Biologics, Inc.(TOVX)
Biotechnology
Oncology Biotech
| Filing Date | Insider | Type | 10b5-1 | Net Shares | Ownership change | Avg. Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| 2023-06-08 | SHALLCROSS STEVEN A CEO and CFO | Purchase | +14,000 | +5.93%250,000 | $0.69 | $9,703 | View SEC filing | |
| 2023-06-07 | SHALLCROSS STEVEN A CEO and CFO | Purchase | +26,000 | +12.38%236,000 | $0.63 | $16,453 | View SEC filing | |
| 2023-02-13 | SHALLCROSS STEVEN A CEO and CFO | Purchase | +25,000 | +13.51%210,000 | $1.04 | $26,075 | View SEC filing | |
| 2023-02-03 | SHALLCROSS STEVEN A CEO and CFO | Purchase | +25,000 | +15.63%185,000 | $0.94 | $23,513 | View SEC filing | |
| 2023-01-26 | SHALLCROSS STEVEN A CEO and CFO | Purchase | +25,000 | +18.52%160,000 | $0.87 | $21,825 | View SEC filing | |
| 2023-01-23 | SHALLCROSS STEVEN A CEO and CFO | Purchase | +25,000 | +22.73%135,000 | $0.75 | $18,705 | View SEC filing | |
| 2023-01-03 | SHALLCROSS STEVEN A CEO and CFO | Purchase | +100,000 | +1000.00%110,000 | $0.44 | $43,700 | View SEC filing | |
| 2021-05-10 | SHALLCROSS STEVEN A CEO and CFO | Purchase | +50,000 | +100.00%100,000 | $0.49 | $24,595 | View SEC filing | |
| 2019-08-26 | SHALLCROSS STEVEN A CEO and CFO | Purchase | +50,000 | +100.00%50,000 | $0.42 | $20,785 | View SEC filing | |
| 2019-04-03 | KIRK RANDAL J 10% Owner | Sale | -150,565 | -39.81%227,674 | $0.66 | $98,837 | View SEC filing | |
| 2015-09-04 | KIRK RANDAL J 10% Owner | Purchase | +937,500 | +10.81%9,613,268 | $3.20 | $3,000,000 | View SEC filing | |
| 2014-05-27 | Ballantyne Charles Evan Chief Financial Officer | Purchase | +10,000 | +100.00%10,000 | $1.35 | $13,500 | View SEC filing | |
| 2014-05-02 | KANZER STEVE H 10% Owner, Other | Sale | -5,003,025 | -69.50%2,195,489 | $1.43 | $7,154,326 | View SEC filing | |
| 2014-04-30 | KANZER STEVE H 10% Owner, Other | Sale | -263,112 | -3.71%6,823,268 | $2.90 | $763,053 | View SEC filing | |
| 2013-12-19 | KIRK RANDAL J 10% Owner | Purchase | +2,500,000 | +25.51%12,300,768 | $1.00 | $2,500,000 | View SEC filing | |
| 2013-01-07 | Riley Jeffrey Scott CEO and President | Purchase | +2,900 | +38.67%10,400 | $0.17 | $506 | View SEC filing | |
| 2013-01-04 | Riley Jeffrey Scott CEO and President | Purchase | +2,000 | +36.36%7,500 | $1.71 | $3,420 | View SEC filing | |
| 2013-01-03 | Riley Jeffrey Scott CEO and President | Purchase | +5,500 | +100.00%5,500 | $1.76 | $9,705 | View SEC filing | |
| 2012-10-31 | KIRK RANDAL J 10% Owner | Purchase | +3,125,000 | +100.00%3,125,000 | $1.60 | $5,000,000 | View SEC filing | |
| 2011-08-31 | KUO JAMES S Chairman, CEO & President | Purchase | +4,500 | +100.00%4,500 | $0.69 | $3,103 | View SEC filing | |
| 2008-04-15 | KANZER STEVE H Chief Executive Officer | Purchase | +7,136,380 | +2194.15%7,461,626 | $0.01 | $44,428 | View SEC filing | |
| 2007-11-13 | DORMAN DANIEL J Director | Purchase | +253,731 | +50.00%761,192 | $2.22 | $563,283 | View SEC filing | |
| 2007-07-26 | KANZER STEVE H CEO | Purchase | +7,100,679 | +2283.57%7,411,625 | $0.01 | $103,281 | View SEC filing | |
| 2007-07-25 | KANZER STEVE H CEO | Purchase | +7,094,379 | +2341.80%7,397,325 | $0.01 | $57,025 | View SEC filing | |
| 2007-07-24 | KANZER STEVE H CEO | Purchase | +7,116,079 | +2604.28%7,389,325 | $0.03 | $200,351 | View SEC filing |
1-25 of 33